Merck (NYSE: MRK) announced that the Hart-Scott-Rodino Act waiting period for its acquisition of Terns Pharmaceuticals (NASDAQ: TERN) expired on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE